Drug Trial Radar · NCT07538583
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
16
Planned (sponsor's estimate)
Start
Mar 19, 2026
Primary completion
Jan 31, 2027
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Quoin PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Apr 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, open-label study to evaluate the safety, tolerability, and efficacy of 4% QRX003 lotion applied twice daily (BID) for 12 weeks to Netherton syndrome (NS) diseased skin in all affected areas of the body excluding the scalp (the Treatment Area), totaling approximately 50% Body Surface Area (BSA) or more.
Conditions
- Netherton Syndrome
Interventions
QRX003Drug
Serine Protease Inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects with 1-point reduction on IGATime frame: Week 12
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
Center for Dermatology Clinical Research
Fremont, California · Recruiting
Yale University School of Medicine
New Haven, Connecticut · Not yet recruiting
Dawes Fretzin Clinical Reseacrh Group
Indianapolis, Indiana · Recruiting
Beacon Clinical Research
Quincy, Massachusetts · Recruiting
Texas Dermatology and Laser Specialists
San Antonio, Texas · Recruiting
Guy's Hospital, Skin Therapy Research Unit
London, United Kingdom · Recruiting
Great Ormond Street Hospital, NIHR - Clinical Research
London, England, United Kingdom · Recruiting
Walsall Manor Hospital, Research & Development
Walsall, West Midlands, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.